Found: 16
Select item for more details and to access through your institution.
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0696-z
- By:
- Publication type:
- Article
Quality of life in the digital age: young adult hematopoietic stem cell transplantation patients and healthcare providers’ views of telehealth.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 4, p. 1, doi. 10.1007/s00520-024-08482-7
- By:
- Publication type:
- Article
Nutritional status and body mass index before hematopoietic stem cell transplantation (HSCT) and associated outcomes: a rapid review.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 1, p. 1, doi. 10.1007/s00520-023-08238-9
- By:
- Publication type:
- Article
Warm Autoimmune Hemolytic Anemia with a Direct Antiglobulin Test Positive for C3 and Negative for IgG: A Case Study and Analytical Literature Review of Incidence and Severity.
- Published in:
- Clinical Medicine Insights: Case Reports, 2013, n. 6, p. 57, doi. 10.4137/CCRep.S11469
- By:
- Publication type:
- Article
Impact of conditioning regimen intensity on the outcomes of peripheral T‐cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T‐cell lymphoma patients undergoing allogeneic transplant.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 2, p. 212, doi. 10.1111/bjh.18052
- By:
- Publication type:
- Article
Ruxolitinib resistance or intolerance in steroid‐refractory acute graft‐versus‐host disease — a real‐world outcomes analysis.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 429, doi. 10.1111/bjh.17700
- By:
- Publication type:
- Article
Mismatched donor allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 6, p. 1196, doi. 10.1002/ajh.27305
- By:
- Publication type:
- Article
Feasibility and Toxicity of Full-Body Volumetric Modulated Arc Therapy Technique for High-Dose Total Body Irradiation.
- Published in:
- Technology in Cancer Research & Treatment, 2023, p. 1, doi. 10.1177/15330338231180779
- By:
- Publication type:
- Article
New Approaches for the Treatment of AML beyond the 7+3 Regimen: Current Concepts and New Approaches.
- Published in:
- Cancers, 2024, v. 16, n. 3, p. 677, doi. 10.3390/cancers16030677
- By:
- Publication type:
- Article
Mindfulness in Adolescent and Young Adult (AYA) Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Qualitative Study.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2760, doi. 10.3390/cancers14112760
- By:
- Publication type:
- Article
Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 6, p. 1936, doi. 10.1002/cam4.3664
- By:
- Publication type:
- Article
Reasons for migration among medical students from Karachi.
- Published in:
- Medical Education, 2008, v. 42, n. 1, p. 61, doi. 10.1111/j.1365-2923.2007.02904.x
- By:
- Publication type:
- Article
Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 400, doi. 10.1016/j.clml.2024.02.005
- By:
- Publication type:
- Article
CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 772, doi. 10.1016/j.clml.2023.05.007
- By:
- Publication type:
- Article
Allogeneic Hematopoietic Cell Transplantation for Richter Syndrome: A Single-Center Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study.
- Published in:
- Cardio-Oncology, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40959-023-00170-5
- By:
- Publication type:
- Article